Gili Pro BioSensor measured heart and breathing rates without contact

In a study of 120 adults that FDA reviewed, the Gili Pro BioSensor met limits of ±3 bpm against ECG and ±2 breaths per minute against capnography, without touching patients.

  • Not rated an organization

    The study measured accuracy, and no reduction in contact or infection among staff was measured.

Depth runs from 1, a convenience or time saved, to 5, a life or a livelihood preserved.

Status
Intended benefit.
Evidence

foundstudiedreportedclaimed

An independent regulatory document supports the benefit.

Compared with

Pre-specified acceptance limits against ECG and capnography. Measured.

Without the system
Limits of ±3 bpm for heart rate and ±2 breaths per minute for breathing rate
With it
Both limits met, with intercepts of 0.51 for heart rate and 0.17 for breathing rate
The system’s part
Not isolated. The study compared the device's readings with ECG and capnography. It did not compare exposure or care with and without the device. FDA reviewers describe software algorithms that analyze the reflected light, and they do not say that the algorithms learned from data.
Limits
Not yet checked.
Costs and harms
Not yet checked.
Later
Not yet checked.

Download data Cite Suggest a correction

Benefit type
Reduced Risk
System
Gili Pro BioSensor (Gili BioSensor System)
Made by
ContinUse Biometrics Ltd.
Used by
ContinUse Biometrics (clinical accuracy study in 120 adults against ECG and capnography)
Stage
In a pilot
Date
, when the source was published
Kind
Aggregate result
Broad benefit
Estimating the Quantifiable Characteristics of Products, Events, or Information, Monitoring Processes, Materials, or Surroundings
Collections
Scrutiny and findings
Last revised
31 October 2026

Sources

  1. Regulatory document, by authors with no tie to the system.

    U.S. Food and Drug Administration, Center for Devices and Radiological Health. De Novo Classification Request for Gili Pro BioSensor (Gili BioSensor System) (DEN200038): decision summary. Granted 2021-04-01.

    The device can provide benefit as heart rate and respiratory rate values are obtained without personal contact with a healthcare worker.

Details

AI system

Workflow

The patient sat upright in a chair or bed, wearing smooth clothing that was snug against the chest. The sensor aimed an eye-safe infrared laser at the chest and recorded the reflected pattern.

Follow-up

Conditions for replication

Healthcare professionals take spot measurements in adults who do not need continuous monitoring. The readings are not used to detect arrhythmias or to monitor apnea.

Entry details

Sector

Healthcare.

Purpose

ContinUse Biometrics built the Gili Pro BioSensor to take spot measurements of heart and breathing rates without touching the patient.

Not yet checked: model, release, provider, role, configuration, inputs and outputs, autonomy, human oversight, AI contribution, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, other identifiers, category mappings.

Cite this record

Peter H. Vartanian. (2026). Gili Pro BioSensor measured heart and breathing rates without contact (AIBD-0782). Artificial Intelligence Benefits Database, edition of 31 October 2026. https://petervartanian.xyz/aibd/records/AIBD-0782.html (archived at https://doi.org/10.7910/DVN/AADSII, version 4.0)

BibTeX Data Field definitions